Clinical Trials · NCT00154401
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 177
- Start date
- Jan 2005
- Locations
- 39 sites, 4 countries
- Primary endpoint
- HbA1c